Fetal Clavicular Measurement to Predict Fetal Macrosomia
Launched by ASSIUT UNIVERSITY · Feb 27, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to predict if a baby will be larger than average (a condition known as macrosomia) before it's born. Macrosomia can lead to complications during delivery, which can be risky for both the mother and the baby. Researchers want to see if measuring the length of the baby's clavicle (the collarbone) in the third trimester is a better method for predicting macrosomia compared to other existing techniques.
To participate in this study, women must be pregnant with a single baby and be between 37 to 42 weeks along in their pregnancy. They also need to agree to take part in the study. Unfortunately, if the baby has any congenital (birth) defects that could affect its weight or clavicle size, they would not be eligible. The trial is not yet recruiting participants, but once it starts, those who join can expect to undergo specific measurements to help researchers learn more about predicting macrosomia, ultimately aiming to improve care for mothers and their babies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Singleton pregnancy.
- • Gestational age between 37-42 weeks.
- • Accepting to be included in the study.
- Exclusion Criteria:
- • Congenital fetal malformation affecting birth weight or affecting clavicle.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alaa ElDin Abdelhamid Yusef Hasan
Study Director
Emeritus Professor of obstetrics and gynecology
Ahmed Mohamed Abbas Sobh
Study Director
Assistant Professor of obstetrics and gynecology
Mohamed Mahmoud Abdallah Mahmoud
Study Director
Lecturer of obstetrics and gynecology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported